News archive for The Department of Biomedicine
At the UiB, health minister Bent Høie met representatives of the health industry and health institutions to receive input for a new parliamentary report on the health industry.
Thomas Arnesen is one of five Norwegian researchers who will receive a prestigious consolidator grant from the European Research Council in 2017.
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
Gry Sandvik Haaland defends her dissertation “Investigations of the cancer therapeutic and protective effects of warfarin mediated inhibition of the receptor tyrosine kinase AXL”
A state-of-the-art imaging system for high-throughput crystallization experiments has been installed at BiSS at the Department of Biomedicine. The system is capable of imaging samples using both visible and UV light. The imager is a significant addition to the crystallization laboratory as well as BiSS, providing a seamless workflow from the Mosquito LCP pipetting robot to automated imaging. It... Read more
Bergen Medical Research Foundation (BFS) has announced to award funding for 4-years to Professor Arvid Lundervold for his project „Computational Medical Imaging and Machine Learning».
The Workshop in Applied Structural Bioinformatics will be organized at the University of Bergen October 16-20. This workshop will provide a practical introduction to popular tools for biomolecular visualisation, analysis and simulations. Lectures will be given by both international and local speakers from the research fields of structural bioinformatics and computer-aided drug design.
In November 2017, the University of Bergen hosted the second annual meeting and winter school for members of the Innovative Training Network "switchBoard"
The Department of Biomedicine is glad to welcome the research group lead by Thomas Arnesen, who is currently moving into their new offices and laboratories.
Ina Katrine Nitschke Pettersen defends her dissertation “A study of cellular metabolic flexibility under energy stress”
Development of novel anticancer and cardioprotective agents that target prohibitins and the translation initiation factor eIF4a
Pages
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009